CymaBay Therapeutics, Inc.
CBAY · NASDAQ
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$42 | -$34 | -$1 | -$29 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | -$4 | -$2 | -$2 | $0 |
| Stock-Based Comp. | $5 | $4 | $3 | $3 |
| Change in WC | $7 | $1 | -$31 | $28 |
| Other Non-Cash | $7 | $5 | $5 | $3 |
| Operating Cash Flow | -$27 | -$26 | -$25 | $6 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | -$1 | -$1 |
| Inv. Purchases | -$116 | -$30 | -$39 | -$121 |
| Inv. Sales/Matur. | $74 | $45 | $40 | $61 |
| Other Inv. Act. | $0 | $15 | $1 | $1 |
| Investing Cash Flow | -$42 | $15 | $1 | -$61 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $3 | $243 | $1 | $92 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3 | $249 | $1 | $93 |
| Financing Cash Flow | $3 | $249 | $1 | $93 |
| Forex Effect | -$0 | $0 | $27 | $0 |
| Net Chg. in Cash | -$67 | $238 | -$24 | $39 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $274 | $35 | $59 | $20 |
| End Cash | $207 | $274 | $35 | $59 |
| Free Cash Flow | -$28 | -$26 | -$26 | $6 |